NCT00298025 A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation Status COMPLETED Phase PHASE4
NCT00294918 An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome Status COMPLETED Phase PHASE2/PHASE3
NCT00294164 Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) Status COMPLETED Phase PHASE2/PHASE3
NCT00292266 A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) Status COMPLETED Phase PHASE3
NCT00292253 Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects Status COMPLETED Phase PHASE3
NCT00262314 Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients Status COMPLETED Phase N/A
NCT00249860 A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects Status COMPLETED Phase PHASE3
NCT00230815 A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction Status COMPLETED Phase PHASE3
NCT00213148 Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction Status COMPLETED Phase PHASE2
NCT00213135 A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3
NCT00133354 Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys Status COMPLETED Phase PHASE2/PHASE3
NCT00132522 EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide Status COMPLETED Phase PHASE1
NCT00111839 Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer Status COMPLETED Phase PHASE2
NCT00110396 Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00109733 Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency Status COMPLETED Phase PHASE3
NCT00105521 Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Status COMPLETED Phase PHASE3
NCT00105508 Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Status COMPLETED Phase PHASE3
NCT00101959 Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects Status WITHDRAWN Phase PHASE4
NCT00093964 Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) Status COMPLETED Phase PHASE2